
A dual-peptide protocol that burns visceral fat and builds lean muscle simultaneously. Tesamorelin targets deep belly fat while Ipamorelin amplifies growth hormone for recovery, sleep, and body composition.
Stubborn visceral abdominal fat, difficulty gaining lean muscle, poor body composition despite consistent training and nutrition, slow recovery, disrupted sleep, and age-related growth hormone decline. This stack is for patients who want to lose fat and gain muscle at the same time rather than choosing one goal over the other. It targets the hormonal environment that makes recomposition possible.
Tesamorelin is a GHRH analog that stimulates pituitary release of growth hormone, driving lipolysis specifically in visceral adipose tissue. Ipamorelin is a selective ghrelin receptor agonist that triggers additional GH pulses without raising cortisol or prolactin. Stacked together, they amplify your natural GH output to support fat metabolism, lean tissue preservation, and overnight recovery simultaneously.
This is our most targeted body recomposition peptide stack, and we prescribe it only when your labs and goals justify both compounds working in parallel. Every protocol includes a clinical consultation, structured dosing cycles, and ongoing monitoring. We source exclusively from 503A pharmacies and adjust based on your response. Lincoln Park clinic or Illinois telehealth.

We're here to answer your questions and provide the best services for your needs. Schedule a consultation to learn how to reach your aesthetic goals.
Total Recomposition uses Tesamorelin—a GHRH analog that preferentially reduces visceral abdominal fat—combined with Ipamorelin, a selective GH secretagogue that supports lean mass, recovery, and performance. Delivered as a cyclical, non‑FDA–approved protocol with informed consent, the program layers nightly or near‑nightly injections, labs (including IGF‑1), and a tailored training and nutrition plan.
Tesamorelin binds to GHRH receptors in the anterior pituitary, increasing pulsatile growth hormone and downstream IGF‑1, which selectively stimulates lipolysis in visceral adipose tissue while largely preserving subcutaneous fat and lean muscle. Clinical data show significant visceral fat (VAT) reduction and improved fat “quality” and lipids in studied populations. Ipamorelin activates the ghrelin/GHS‑R pathway to trigger physiologic GH release with minimal impact on other pituitary hormones, supporting protein synthesis, lean mass, recovery, and metabolic rate. Together, the stack promotes a recomposition effect: less deep belly fat, better muscle tone, and improved metabolic markers under medical supervision.
Our Tesamorelin + Ipamorelin peptide blendis designed to target:
Tesamorelin + Ipamorelin is believed to help with: